Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Multiple Myeloma 12Recurrence 6Sarcoma 2Neurofibrosarcoma 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myeloid, Acute 2Wilms Tumor 1Vascular Neoplasms 1Triple Negative Breast Neoplasms 1Solitary Fibrous Tumors 1Smooth Muscle Tumor 1Smoldering Multiple Myeloma 1Sarcoma, Clear Cell 1Sarcoma, Alveolar Soft Part 1Rhabdoid Tumor 1Ovarian Neoplasms 1Osteosarcoma 1Nerve Sheath Neoplasms 1Neoplasms, Plasma Cell 1Neoplasms, Adipose Tissue 1Myoepithelioma 1Lymphoma 1Liposarcoma, Myxoid 1Liposarcoma 1Histiocytoma, Angiomatoid Fibrous 1Hemangiosarcoma 1Hemangioendothelioma, Epithelioid 1Granuloma, Plasma Cell 1Granular Cell Tumor 1Glomus Tumor 1

Interventions

atezolizumab 2trifluridine tipiracil drug combination 1selinexor 1pembrolizumab 1futibatinib 1anlotinib 1Zoledronic Acid 1Tablets 1TAS-116 1Specimen Handling 1Rosuvastatin Calcium 1Ramucirumab 1Midazolam 1Gemcitabine 1Fluorouracil 1Digoxin 1Dactinomycin 1Dacarbazine 1Cisplatin 1Carboplatin 1Biopsy 1Bevacizumab 14-(2-fluoro-4-((((2-phenylacetyl)amino)thioxomethyl)amino)phenoxy)-7-methoxy-N-methyl-6-quinolinecarboxamide 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Sarcoma, Alveolar Soft Part × selinexor × Clear all
NCT05333458 2026-05-13

Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, The AXIOM Trial

National Cancer Institute (NCI)

Phase 2 Recruiting
27 enrolled
Sarcoma

Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon âš¡